We further validated the specificity and sensitivity of HSAN for positively gating on neuroblastoma cells in marrow by also using another non-GD2 neuroblastoma antibody (459) [37,38] that does not bind to normal blood or bone marrow. Here, NAA50 is linked to neuroblastoma.